HUTCHMED (China) (HMDCF) Change in Working Capital (2020 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Change in Working Capital came in at $4.4 million in Q1 2021, up 1284.22% year-over-year from $319962.5 in Q1 2020, and up 1284.22% quarter-over-quarter from -$374000.0 in Q1 2020.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Change in Working Capital (2020 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Change in Working Capital for 2 consecutive years, with $4.4 million the latest figure, recorded in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | - |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |